-
1
-
-
0032894841
-
Low-dose prostacyclin is superior to terbutaline and aminophylline in reducing capillary permeability in cat skeletal muscle in vivo
-
1. Möller AD, Grände P-O: Low-dose prostacyclin is superior to terbutaline and aminophylline in reducing capillary permeability in cat skeletal muscle in vivo. Crit Care Med 1999; 27: 130-136
-
(1999)
Crit Care Med
, vol.27
, pp. 130-136
-
-
Möller, A.D.1
Grände, P.-O.2
-
3
-
-
0030945372
-
Radionuclide assessment of pulmonary microvascular permeability
-
3. Groeneveld ABJ: Radionuclide assessment of pulmonary microvascular permeability. Eur J Nucl Med 1997; 24:449-461
-
(1997)
Eur J Nucl Med
, vol.24
, pp. 449-461
-
-
Groeneveld, A.B.J.1
-
4
-
-
0018404289
-
Isoproterenol and aminophylline reduce lung capillary filtration during high permeability
-
4. Foy T, Marion J, Brigham KL, et al: Isoproterenol and aminophylline reduce lung capillary filtration during high permeability. J Appl Physiol 1979; 46:146-151
-
(1979)
J Appl Physiol
, vol.46
, pp. 146-151
-
-
Foy, T.1
Marion, J.2
Brigham, K.L.3
-
5
-
-
0018460407
-
Morphological and physiological correlation of bradykinin-induced macromolecular efflux
-
5. Svensjö E, Arfors K-E, Raymond RM, et al: Morphological and physiological correlation of bradykinin-induced macromolecular efflux. Am J Physiol 1979; 236:H600-H606
-
(1979)
Am J Physiol
, vol.236
-
-
Svensjö, E.1
Arfors, K.-E.2
Raymond, R.M.3
-
6
-
-
0025813113
-
Effects of tumor necrosis factor on prostacyclin production and the barrier function of human endothelial cell monolayers
-
6. Langeler EG, Fiers W, Van Hinsbergh VWM: Effects of tumor necrosis factor on prostacyclin production and the barrier function of human endothelial cell monolayers. Arteriosclerosis and Thrombosis 1991; 11:872-881
-
(1991)
Arteriosclerosis and Thrombosis
, vol.11
, pp. 872-881
-
-
Langeler, E.G.1
Fiers, W.2
Van Hinsbergh, V.W.M.3
-
7
-
-
0029165542
-
TNF modulates endothelial properties by decreasing cAMP
-
7. Koga S, Morris S, Ogawa S, et al: TNF modulates endothelial properties by decreasing cAMP. Am J Physiol 1995; 268:C1104-C1113
-
(1995)
Am J Physiol
, vol.268
-
-
Koga, S.1
Morris, S.2
Ogawa, S.3
-
8
-
-
0030807958
-
2++-inhibitable adenylyl cyclase and pulmonary microvascular permeability
-
2++-inhibitable adenylyl cyclase and pulmonary microvascular permeability. Am J Physiol 1997; 273: L22-L30
-
(1997)
Am J Physiol
, vol.273
-
-
Chetham, P.M.1
Guldemeestr, H.A.2
Mons, N.3
-
9
-
-
0029114356
-
Pentoxifylline inhibits FMLP-induced macromolecular leakage
-
9. Nagakawa K, Miller FN, Knott AW, et al: Pentoxifylline inhibits FMLP-induced macromolecular leakage. Am J Physiol 1995; 269:H239-H245
-
(1995)
Am J Physiol
, vol.269
-
-
Nagakawa, K.1
Miller, F.N.2
Knott, A.W.3
-
10
-
-
0025219061
-
Effects of N-acetylcysteine and terbutaline treatment on hemodynamics and regional albumin extravasation in porcine septic shock
-
10. Groeneveld ABJ, Den Hollander W, Straub J, et al: Effects of N-acetylcysteine and terbutaline treatment on hemodynamics and regional albumin extravasation in porcine septic shock. Circ Shock 1990; 30:185-205
-
(1990)
Circ Shock
, vol.30
, pp. 185-205
-
-
Groeneveld, A.B.J.1
Den Hollander, W.2
Straub, J.3
-
11
-
-
0027195164
-
Role of phosphodiesterases in the regulation of endothelial permeability in vitro
-
11. Suttorp N, Weber U, Welsch T, et al: Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest 1993; 91: 1421-1428
-
(1993)
J Clin Invest
, vol.91
, pp. 1421-1428
-
-
Suttorp, N.1
Weber, U.2
Welsch, T.3
-
12
-
-
0030066888
-
Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin
-
12. Fujii E, Irie K, Ogawa A, et al: Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin. Eur J Pharmacol 1996; 297:257-263
-
(1996)
Eur J Pharmacol
, vol.297
, pp. 257-263
-
-
Fujii, E.1
Irie, K.2
Ogawa, A.3
-
13
-
-
0030615190
-
2): New aspects of an old substance in the treatment of critically ill patients
-
2): New aspects of an old substance in the treatment of critically ill patients. Intensive Care Med 1997; 23:146-158
-
(1997)
Intensive Care Med
, vol.23
, pp. 146-158
-
-
Scheeren, T.1
Radermacher, P.2
|